<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-06-03T19:10:24Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/ahr.000022">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/ahr.000022</identifier>
									<datestamp>2019-07-26</datestamp>
									<setSpec>PTZ.AHR:VOL5</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Occult Hepatitis B Virus infection in a cohort of patients with chronic Hepatitis C
										</dc:title><dc:creator>MI Naga</dc:creator><dc:creator> MA Amin</dc:creator><dc:creator> DA Algendy</dc:creator><dc:creator> AI El Badry</dc:creator><dc:creator> MM Fawzi</dc:creator><dc:creator> AR Foda</dc:creator><dc:creator> SM Esmat</dc:creator><dc:creator> SM Gabal</dc:creator><dc:creator> D Sabry</dc:creator><dc:creator> M Kamal</dc:creator><dc:creator> LA Rashed</dc:creator><dc:description>&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: The prevalence of occult hepatitis B, defi ned by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may infl uence the treatment of hepatitis C and the severity of liver disease&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim of work and methods&lt;/strong&gt;: Was to determine the prevalence of occult hepatitis B virus infection and liver of HBsAg negative patients with chronic hepatitis C and to evaluate its clinical consequences on liver pathology and its impact on the response to treatment with peg-IFNa and Ribavirin. Immunohistochemistry staining for hepatitis B surface antigen and HBV DNA detection was assessed retrospectively on liver biopsies of HCV positive/ HBsAg negative patients before treatment.&lt;/p&gt;</dc:description>
										<dc:publisher>Archives of Hepatitis Research - Peertechz Publications</dc:publisher>
										<dc:date>2019-07-26</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/ahr.000022</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © MI Naga et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
